Drugs.com - Pharma Industry News

Midafternoon Dosing Improves Lung Function in Atopic Asthma

FRIDAY, April 18, 2025 -- Midafternoon dosing with beclomethasone dipropionate is associated with better clinical outcomes in mild-to-moderate atopic asthma, according to a study published online April 15 in Thorax.Ran Wang, Ph.D., from the NIHR...

Apr 18, 2025 - 19:00
 0
Midafternoon Dosing Improves Lung Function in Atopic Asthma
FRIDAY, April 18, 2025 -- Midafternoon dosing with beclomethasone dipropionate is associated with better clinical outcomes in mild-to-moderate atopic asthma, according to a study published online April 15 in Thorax.Ran Wang, Ph.D., from the NIHR...
Read More

Tags:

Previous Article

CBRE 2025 Outlook: Investor Confidence in European Hotel Sector Remains High

Next Article

Acute Care for Cannabis Use Increases Risk for Subsequent New Dementia Diagnosis

Related Posts

Adults Prefer Messages Written by AI in Communication With Doctors

Adults Prefer Messages Written by AI in Communication W...

Mar 13, 2025  0

2005 to 2019 Saw Increase in Incidence of Cervical Artery Dissection

2005 to 2019 Saw Increase in Incidence of Cervical Arte...

Apr 4, 2025  0

CT Exams in 2023 Projected to Result in 103,000 Future Cancers

CT Exams in 2023 Projected to Result in 103,000 Future ...

Apr 17, 2025  0